Skip to main content
EVH logo

EVH · Evolent Health, Inc. · Executive Compensation

Track EVH — free
$3.90 +0.47 (+13.70%) At close · Nov 20 Play latest call Q3 2026 earnings call transcript
Market Cap
$441.11M
Shares
113.11M
Volume · Nov 20 4.42M Avg daily vol (3M) 2.16M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Seth Blackley $14,240,154
Daniel McCarthy $9,623,279
John Johnson $5,370,671
Jonathan Weinberg $2,639,664
Emily Rafferty $2,404,625
Fiscal 2024
Executive Total
Seth Blackley $11,136,185
Daniel McCarthy $7,484,923
John Johnson $4,814,291
Emily Rafferty $2,009,212
Jonathan Weinberg $1,966,449
Fiscal 2023
Executive Total
Seth Blackley $8,931,188
Daniel McCarthy $5,763,625
Emily Rafferty $5,763,625
John Johnson $3,530,596
Steve Tutewohl $2,374,018
Jonathan Weinberg $2,012,894
Fiscal 2022
Executive Total
Seth Blackley $7,725,414
Daniel McCarthy $3,484,767
John Johnson $3,186,217
Steve Tutewohl $1,854,033
Jonathan Weinberg $1,518,065
Fiscal 2021
Executive Total
Seth Blackley $6,526,285
John Johnson $2,544,800
Steve Tutewohl $1,963,735
Jonathan Weinberg $1,424,583
Aammaad Shams $634,883
Fiscal 2020
Executive Total
Seth Blackley $3,972,700
Frank Williams $3,043,400
John Johnson $1,488,600
Steve Tutewohl $1,452,750
Jonathan Weinberg $876,667
Aammaad Shams $316,234
Fiscal 2019
Executive Total
Frank Williams $4,103,000
Seth Blackley $3,052,667
Thomas Peterson $1,777,500
Nicholas McGrane $1,308,750
Jonathan Weinberg $1,102,233
John Johnson $1,039,167
Fiscal 2018
Executive Total
Frank Williams $3,311,000
Seth Blackley $2,211,000
Thomas Peterson $1,086,000
Nicholas McGrane $1,007,700
Jonathan Weinberg $636,000
Fiscal 2017
Executive Total
Frank Williams $3,160,800
Seth Blackley $2,110,800
Thomas Peterson $1,017,050

Executive changes

Person Change Filed
Jill Smith Appointed 2025-12-02
Cheryl Scott
“Ms. Scott’s decision to retire was not the result of any disagreement between the Company and Ms. Scott on any matter relating to the Company’s operations, policies or practices.”
Retired 2025-12-02
Felicia Crawford-Smith Appointed 2025-11-06
Katie DiPerna Appointed 2025-11-06
Emily Rafferty Appointed 2025-11-06
John Johnson Appointed 2025-11-06
Mario Ramos Appointed 2025-11-06
Cheryl Scott Appointed 2025-06-05
Brendan Springstubb Appointed 2025-06-05
Shawn Guertin Appointed 2025-06-05
Peter Grua Appointed 2025-06-05
Kim Keck Appointed 2025-06-05
Richard Jelinek Appointed 2025-06-05
Seth Blackley Appointed 2025-06-05
Russell Glass Appointed 2025-06-05
Craig Barbarosh Appointed 2025-06-05
Toyin Ajayi, MD Appointed 2025-06-05
Brendan Springstubb Appointed 2025-02-04
Richard "Rick" Jelinek Appointed 2025-02-04
Brendan Springstubb Appointed 2025-02-04
M. Bridget Duffy, MD
“Dr. Duffy’s decision to resign was not the result of any disagreement between the Company and Dr. Duffy on any matter relating to the Company’s operations, policies, or practices.”
Resigned 2025-02-04
Russell Glass Appointed 2024-02-14
Dr. Tunde Sotunde
“Dr. Sotunde’s decision to retire was not the result of any disagreement between the Company and Dr. Sotunde on any matter relating to the Company’s operations, policies, or practices.”
Retired 2024-02-14
Toyin Ajayi Appointed 2023-07-26
Emily Rafferty Appointed 2023-05-03

Leadership

Key facts CIK 1628908 CUSIP 30050B101 13F (30d) 212 filings 189 filers Visit website Investor relations